Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New drugs could help fight antibiotic resistance
Image pills
Current antibiotics work by killing bacteria, or stopping it from growing.
AV drugs stop bacteria from harming the host

Scientists say a new type of drug could help fight antibiotic resistance, by stopping bacteria from harming the host.

Current antibiotics aim to kill bacteria, or stop them growing, but scientists from the University of Edinburgh say this dramatically alters how the bugs evolve and helps resistant strains to survive.

After conducting a five-year review of research in the field, scientists believe anti-virulence (AV) drugs could stop the growing resistance to antibiotics.

AV drugs work by stopping the harmful part of the bacteria from functioning - without directly harming or killing the bugs. In this way, the treat the infection without promoting drug resistance.

Experts warn that as antibiotic resistance grows, curable infections could become life-threatening if the bacteria responsible becomes immune to current treatments.

According to the team from Edinburgh, recent research suggests AV drugs could provide an effective and longer lasting alternative to existing treatments.

Findings indicate the new drugs could work well alone, or combined with existing drugs.

"Our findings reveal that there are opportunities to make real progress in the fight against antibiotic resistance," said researcher Richard Allen.

"Gaining a greater understanding of how virulence affects bacterial growth in the host should aid us in our efforts to develop effective AV drugs."

The study has been published in the journal Nature Reviews Microbiology.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.